5.23
price up icon0.19%   0.01
after-market Dopo l'orario di chiusura: 5.23
loading
Precedente Chiudi:
$5.22
Aprire:
$5.24
Volume 24 ore:
5,482
Relative Volume:
0.24
Capitalizzazione di mercato:
$192.43M
Reddito:
$7.80M
Utile/perdita netta:
$-69.02M
Rapporto P/E:
-2.4424
EPS:
-2.1413
Flusso di cassa netto:
$-66.61M
1 W Prestazione:
-1.84%
1M Prestazione:
+4.81%
6M Prestazione:
-17.96%
1 anno Prestazione:
+12.47%
Intervallo 1D:
Value
$5.23
$5.24
Intervallo di 1 settimana:
Value
$5.22
$5.41
Portata 52W:
Value
$3.32
$12.70

Molecular Partners Ag Adr Stock (MOLN) Company Profile

Name
Nome
Molecular Partners Ag Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
167
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-26
Name
Ultimi documenti SEC
Name
MOLN's Discussions on Twitter

Confronta MOLN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MOLN
Molecular Partners Ag Adr
5.23 192.43M 7.80M -69.02M -66.61M -2.1413
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-08-30 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-08-29 Downgrade SVB Leerink Outperform → Mkt Perform
2022-05-25 Aggiornamento Credit Suisse Underperform → Neutral
2022-04-27 Downgrade Credit Suisse Neutral → Underperform
2021-07-13 Iniziato Cowen Outperform
2021-07-12 Ripresa SVB Leerink Outperform
Mostra tutto

Molecular Partners Ag Adr Borsa (MOLN) Ultime notizie

pulisher
Jan 12, 2025

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 12, 2025
pulisher
Dec 13, 2024

Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance

Dec 13, 2024
pulisher
Dec 13, 2024

Here's Why Seagate (STX) is a Strong Momentum Stock - Yahoo Finance

Dec 13, 2024
pulisher
Oct 31, 2024

Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks

Oct 31, 2024
pulisher
Oct 22, 2024

Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks

Oct 22, 2024
pulisher
Oct 22, 2024

Molecular Partners expands 212Pb co-development agreement with Orano Med - TipRanks

Oct 22, 2024
pulisher
Oct 08, 2024

Molecular Partners shares gain on Leerink's outperform rating - Investing.com

Oct 08, 2024
pulisher
Jun 21, 2024

Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga

Jun 21, 2024
pulisher
Jun 11, 2024

Molecular Partners Unveils Promising Cancer Therapy - TipRanks

Jun 11, 2024
pulisher
Jun 03, 2024

Molecular Partners Shares Rise on Positive Trial Data for MP0317 - MarketWatch

Jun 03, 2024
pulisher
Apr 20, 2023

Molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero (NASDAQ:MOLN) - Seeking Alpha

Apr 20, 2023
pulisher
Apr 27, 2022

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com UK

Apr 27, 2022
pulisher
Apr 24, 2022

US stock market gainers for the last week of April 2022 - Nairametrics

Apr 24, 2022
pulisher
May 15, 2019

Market Data Center - Barron's

May 15, 2019

Molecular Partners Ag Adr Azioni (MOLN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Capitalizzazione:     |  Volume (24 ore):